Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
24 août 2021 16h05 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Adamis Pharmaceuticals Provides an Update on ZIMHI™
12 avr. 2021 07h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the status of the company’s New Drug Application (NDA) relating to its...
Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others
01 oct. 2020 04h59 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types,...
Preventing Anaphylaxis
01 août 2019 14h06 HE
|
The Jackson Laboratory
Farmington, Connecticut, Aug. 01, 2019 (GLOBE NEWSWIRE) -- An antibody, known as IgE, is the culprit in allergic reactions to everything from peanuts to tree pollen. A kind of super-antibody, known...
Global Autoinjectors Market is Set to Reach USD 4.5 Billion by 2024, Growing at a CAGR of 16.9% During the Forecast Period: VynZ Research
03 juin 2019 06h18 HE
|
VynZ Research
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- The global autoinjectors market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The...
Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
15 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....
Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
02 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...
Anaphylaxis and the Importance of Always Having an EpiPen
09 oct. 2017 03h00 HE
|
Allergy Partners
ASHEVILLE, N.C., Oct. 09, 2017 (GLOBE NEWSWIRE) -- EpiPen and EpiPen Jr are injectable forms of epinephrine used to treat anaphylaxis, which is a severe form of an allergic reaction. Anaphylaxis is...
Study: Fewer than half of children with severe allergies receive life-saving epinephrine
28 août 2017 10h15 HE
|
London Drugs Ltd.
RICHMOND, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) -- When children with life threating allergies experience anaphylaxis, parents, teachers and other caregivers often fail to administer...
Adan Medical Innovation Announces Launch of Clinical Trial for anAPPhylaxis—Its Smart Case and Mobile Phone App for Epinephrine Autoinjectors
25 avr. 2016 09h52 HE
|
Adan Medical Innovation, S.L.
BARCELONA, Spain, April 25, 2016 (GLOBE NEWSWIRE) -- Adan Medical Innovation, SL. (Adan MI), a privately held biotech firm developing advanced tools and medical devices that assist in the...